` ABT (Abbott Laboratories) vs S&P 500 Comparison - Alpha Spread

ABT
vs
S&P 500

Over the past 12 months, ABT has outperformed S&P 500, delivering a return of 25% compared to the S&P 500's 11% growth.

Stocks Performance
ABT vs S&P 500

Loading

Performance Gap
ABT vs S&P 500

Loading
ABT
S&P 500
Difference

Performance By Year
ABT vs S&P 500

Loading
ABT
S&P 500
Add Stock

Competitors Performance
Abbott Laboratories vs Peers

Abbott Laboratories
Glance View

Economic Moat
Narrow
Market Cap
226.7B USD
Industry
Health Care

Nestled into the landscape of global healthcare, Abbott Laboratories emerges as a stalwart that champions scientific innovation and broad accessibility. Established in 1888 by Dr. Wallace Calvin Abbott, the company evolved from a modest medicinal compounding business into a diversified healthcare conglomerate. Today, Abbott's reach extends across more than 160 countries, where it dedicates itself to advancing human health through a wide array of products, including diagnostics, medical devices, nutritionals, and branded generic medicines. This diverse portfolio enables Abbott to remain resilient amid varying market conditions, ensuring its stability and growth are less susceptible to the cyclical nature of any single healthcare segment. Central to Abbott's operations is its prowess in diagnostics and medical devices, both sectors contributing significantly to the company's bottom line. Diagnostics equip healthcare providers with advanced tools to detect diseases early, tailoring treatments to improve patient outcomes—a demand ballooning in tandem with global health awareness. Moreover, Abbott’s innovative medical devices, from cardiovascular to neuromodulation technologies, address some of the most pressing health challenges. Meanwhile, the company’s nutrition products, such as infant formulas and dietary supplements, tap into a burgeoning global appetite for health-conscious living. Each of these ventures feeds into Abbott's strategy of sustaining growth through constant innovation, strategic international expansion, and responsiveness to healthcare trends and needs worldwide. It's this blend of diversification and specialization that keeps the company at the forefront of the healthcare arena.

ABT Intrinsic Value
104.88 USD
Overvaluation 20%
Intrinsic Value
Price
Back to Top